From thrombolytic megatrials to clinical policy-making: facing the facts.
Naylor
C D
CD
Department of Medicine, University of Toronto.
Armstrong
P W
PW
D002170:Canada; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D017408:Guidelines as Topic; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014481:United States
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator